Sercómex Pharma reached 50,000 participants in its omnichannel programs
Home News Sercómex Pharma reached 50,000 participants in its omnichannel programs

Sercómex Pharma reached 50,000 participants in its omnichannel programs

MARCH 5, 2024 BHH Members Initiatives

BHH member Sercómex Pharma, experts in the development of omnichannel commercial promotion programs, continues its unstoppable growth and exceeds 130 omnichannel medical visit programs, with an overall of 50,000 HCPs contacted.

Through programs of various kinds - launches, promotion of mature products, pathology awareness, patient support programs... - these data reflect, not only the growth of remote medical visits but also the natural incorporation of such visits into the business plans of pharmaceutical companies.

Managing the preferred channels of healthcare professionals and adapting to when and how they prefer to be contacted, is undoubtedly the best option to improve HCP engagement.

Since 2011, Sercómex Pharma has developed omnichannel trade promotion programs through their 4 business areas. Their added value is hyper-personalization, based on exhaustive management of the information collected and the definition of the HCP's individual preferences. The result is HCP adherence to their programs, with more than 95% fidelity.

Discover more about Sercómex Pharma and what they do HERE.

December 03, 2024 BHH Members Initiatives
Barça Innovation Hub joins Genomcore shareholders
Barça Innovation Hub (BIHUB) co-invests alongside US-based investment firm QVIDTVM to support Genomcore’s expansion in biomedical data management and sports innovation.
Read more
November 25, 2024 BHH Members Initiatives
VB Devices expands its international presence with VARIXIO to over 30 countries
VB Devices will have expanded its international presence with VARIXIO to over 30 countries by the end of 2024. 
Read more
November 18, 2024 BHH Members Initiatives
Virtuleap launches Cogniclear VR for early cognitive screening
Cogniclear VR immerses users in realistic virtual environments to deliver more precise, objective evaluations of cognitive function.
Read more
November 13, 2024 BHH Members Initiatives
Participate in the lottery to mitigate pharmaceutical poverty
Once again Banco Farmacéutico sells lottery tickets in order to mitigate pharmaceutical poverty.
Read more
November 11, 2024 BHH Members Initiatives
Spanish HCB Hospitales introduces online care with Dutch technology
Spanish HCB Hospitales (Hospital Clínica Benidorm) becomes the first hospital in Spain to use screen care from Webcamconsult.
Read more
November 07, 2024 BHH Members Initiatives
Keito Group to participate in the global healthcare technology event Medica, in Düsseldorf
Keito Group is excited to announce its participation in the upcoming Medica 2024 trade fair, held from 11 to 14 November 2024 in Düsseldorf, Germany.
Read more
November 05, 2024 BHH Members Initiatives
Low Code and AI: Revolutionizing medicine with Onizea
Low Code platforms are empowering healthcare professionals to create custom applications—fast.
Read more
October 29, 2024 BHH Members Initiatives
FemmeUp and SANNO collaborate to raise awareness about women’s health, focusing on menopause and gut health
This collaboration aims to provide comprehensive solutions by combining FemmeUp's expertise in natural supplements with SANNO's patient management software for clinics and research.
Read more
October 29, 2024 BHH Members Initiatives
INBRAIN Neuroelectronics raises $50M Series B to advance graphene-based brain-computer interface technology
VC funding led by imec.xpand, with significant participation from the EIC Fund (venture arm of the European Innovation Council) and continued support from existing investors Asabys Partners and Aliath Bioventures.
Read more
October 28, 2024 BHH Members Initiatives
Reig Jofre enters the digital health market with remote joint physiotherapy services based on AI
The pharmaceutical company has partnered with Catalan startup DyCare to offer digital solutions that allow patients to perform exercises at home, expanding its presence in both the Spanish and French markets.
Read more